R. Brigg Turner, PharmD, BCPS

Phone Number: 
UC Box: 


Block coordinator

PHRM 686 | Infectious Diseases III 

PHRM 684 | Acute Care and Nutrition


PHRM 681 | Infectious Diseases I

PHRM 682 | Infectious Diseases II


2013 | PGY-2 Infectious Diseases Pharmacy Residency, West Virginia University Healthcare, Morgantown, W.V. 

2012 | PGY-1 Pharmacy Residency, West Virginia University Healthcare, Morgantown, W.V. 

2011 | Doctor of Pharmacy, Lake Erie College of Osteopathic Medicine, Erie, Pa. 

2007 | Bachelor of Science, Neuroscience, Brigham Young University, Provo, Utah

Areas of Research & Specialization

Interest areas include infectious diseases, antimicrobial resistance, antimicrobial stewardship, and pharmacokinetics/pharmacodynamics of antimicrobials.

Clinical Practice Site

Legacy Health, Emanuel Medical Center, Portland, OR.

Publications and Poster Presentations

Turner RB, Grover A, Malhotra A. The Clinical Management of Pancreatic Cancer. U.S. Pharmacist. 2014: 1-4.

Turner RB, Smith CB, Martell JL, Slain D. Role of Doxycycline in Clostridium difficile Infection Acquisition. Annals of Pharmacotherapy. 2014; 48(6): 772-6.

Turner RB, Slain D. Colistin Dosing: What is the Current Approach? Making a Difference in Infectious Diseases Pharmacotherapy. 2014; 4(1): 5-15.

Turner RB, Biondo L, Slain D, Phillips U, Cardenas S, Moffett K. A Randomized Pilot Study of Continuous Versus Intermittent Infusion Piperacillin-Tazobactam for the Treatment of Pulmonary Exacerbations in Patients with Cystic Fibrosis. Poster presented at the Annual North American Cystic Fibrosis Conference; Salt Lake City, UT: October 2013. 

Turner RB, Biondo L. Twice Daily Dosing of Tobramycin Improves Attainment of Pharmacokinetic Parameters in Pediatric Patients with Cystic Fibrosis. Poster presented at the Annual North American Cystic Fibrosis Conference; Salt Lake City, UT: October 2013. 

Kirk H, Turner RB, Sweet M, LaSala PR, Slain D, Khakoo R. Comparison of Methicillin-Resistant Staphylococcus aureus Contamination Rates of Medication Cabinets Between Isolation and Non-Isolation Rooms. Accepted for presentation at IDWeek 2013; San Francisco, CA: October 2013. 

Turner RB, Keller L, Slain D, Petros K, Sarwari A. Prolonged Infusion of Cephalosporins Did Not Improve Outcomes in Gram-Negative Infections in the Clinical Setting. Accepted for presentation at ICAAC 2013, American Society of Microbiology; Denver, CO: September 2013. 

Turner RB, Keller L, Slain D. Treatment of Vancomycin-Resistant Enterococci (VRE) Isolated from Urinary Samples. Poster presented at the Midyear Clinical Meeting, abstract [315029], American Society of Health-System Pharmacists; Las Vegas, NV: December 2012. 

Turner RB, Vroman B, Ulisse C, Mehta A, Corso T, Devi SS. Primed mice are protected from liver injury following a normally lethal dose of acetaminophen. Poster presented at the Annual Spring Meeting, Allegheny-Erie Society of Toxicology; Pittsburgh, Pennsylvania: April, 2010. 

Turner RB, Vagula M, Devi SS. Osteoporosis: an understated complication of diabetes. U.S. Pharmacist. May 2009(Diabetes suppl); 34(5):14-16.

Office Location: 
Creighton Hall 452

By Appointment

Area of Study I Teach (Graduate/Professional):